Gadodiamide | Interleukin Related interleukin-related.com

Product Name :
Gadodiamide

Search keywords :
Gadodiamide

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Undisclosed

First Approval Country :
United States

First Approval Date Filter:
1993

Origin Company_Name :
Ge Healthcare

Active Company_Name :
Ge Healthcare

Active Indication_Name:
Contrast agents

In Active Indication_Name:
Arterial Occlusive Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Telisotuzumab Autophagy
CD11b Rabbit mAb custom synthesis
Synaptophysin Antibody (YA664): Synaptophysin Antibody (YA664) is a non-conjugated and Mouse origined monoclonal antibody about 34 kDa, targeting to Synaptophysin (10C8). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts